SBH
NTUS

Segall Bryant & Hamill’s Natus Medical Inc NTUS Stock Holding History

Segall Bryant & Hamill’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-137,587
Closed -$4.38M – 865
2019
Q3 		$4.38M Sell
137,587
-5,664
-4% -$165K 0.07% 296
2019
Q2 		$3.68M Buy
143,251
+18,495
+15% +$471K 0.06% 314
2019
Q1 		$3.17M Buy
+124,756
New +$3.72M 0.05% 334

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Segall Bryant & Hamill's NTUS Position: Q4 2019 in Review

Segall Bryant & Hamill sold out of Natus Medical Inc (NTUS) in Q4 2019, closing a stake of 137,587 shares — an estimated $4.38M sold.

Segall Bryant & Hamill first reported a position in NTUS in Q1 2019 and held it in 3 quarters. The position peaked at $4.38M in Q3 2019. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2019.

  • Segall Bryant & Hamill reported no remaining Natus Medical Inc position as of Q4 2019 after selling out during the quarter.
  • Segall Bryant & Hamill sold 137,587 Natus Medical Inc shares in Q4 2019, an estimated $4.38M.
  • Segall Bryant & Hamill first reported a position in Natus Medical Inc in Q1 2019 and held it in 3 quarters.
  • Segall Bryant & Hamill's Natus Medical Inc position peaked at $4.38M in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2019.

Based on Segall Bryant & Hamill's 13F filing for Q4 2019, filed 11 Feb 2020.